122 related articles for article (PubMed ID: 26064415)
1. Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.
Liu P; Xie G; Geng P; Zheng C; Li J; Pan F; Ruan Z; Liang H
Int J Clin Exp Med; 2015; 8(3):4744-52. PubMed ID: 26064415
[TBL] [Abstract][Full Text] [Related]
2. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
3. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma.
Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J
Cells; 2019 May; 8(5):. PubMed ID: 31121964
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth.
Ruan Z; Yang Z; Wang Y; Wang H; Chen Y; Shang X; Yang C; Guo S; Han J; Liang H; Wu Y
J Immunother; 2009 Jun; 32(5):486-91. PubMed ID: 19609240
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antileukemia effect of combinational gene therapy using murine beta-defensin 2 and IL-18 in L1210 murine leukemia model.
Xu B; Dong CY; Zhang F; Lin YM; Wu KF; Ma XT
Gene Ther; 2007 Aug; 14(15):1181-7. PubMed ID: 17495947
[TBL] [Abstract][Full Text] [Related]
7. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
8. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses.
Ma XT; Xu B; An LL; Dong CY; Lin YM; Shi Y; Wu KF
Cancer Res; 2006 Jan; 66(2):1169-76. PubMed ID: 16424055
[TBL] [Abstract][Full Text] [Related]
9. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.
Felicetti P; Mennecozzi M; Barucca A; Montgomery S; Orlandi F; Manova K; Houghton AN; Gregor PD; Concetti A; Venanzi FM
Cytotherapy; 2007; 9(1):23-34. PubMed ID: 18236207
[TBL] [Abstract][Full Text] [Related]
10. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag.
Felicetti P; Mennecozzi M; Barucca A; Montgomery S; Orlandi F; Manova K; Houghton AN; Gregor PD; Concetti A; Venanzi FM
Cytotherapy; 2007; 9(1):23-34. PubMed ID: 17361485
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells transduced with TEM8 recombinant adenovirus prevents hepatocellular carcinoma angiogenesis and inhibits cells growth.
Yang X; Zhu H; Hu Z
Vaccine; 2010 Oct; 28(43):7130-5. PubMed ID: 20650339
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
[TBL] [Abstract][Full Text] [Related]
13. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
Park JS; Kim HS; Park HM; Kim CH; Kim TG
Vaccine; 2011 Nov; 29(47):8642-8. PubMed ID: 21945963
[TBL] [Abstract][Full Text] [Related]
14. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
15. Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma.
Liu TT; Wu Y; Niu T
Oncotarget; 2018 Jan; 9(1):178-191. PubMed ID: 29416605
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.
Fujinami N; Yoshikawa T; Sawada Y; Shimomura M; Iwama T; Sugai S; Kitano S; Uemura Y; Nakatsura T
Biochem Biophys Rep; 2016 Mar; 5():482-491. PubMed ID: 28955856
[TBL] [Abstract][Full Text] [Related]
17. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
18. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
[TBL] [Abstract][Full Text] [Related]
19. Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy.
Zhang M; Berndt BE; Chen JJ; Kao JY
J Immunol; 2008 Sep; 181(5):3690-7. PubMed ID: 18714045
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models.
Xie K; Bai RZ; Wu Y; Liu Q; Liu K; Wei YQ
Genet Vaccines Ther; 2009 Jun; 7():10. PubMed ID: 19545394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
